Research project
PR2005_20/01
Novel comprehensive immunotherapy to specifically target the malignant clone in Sézary syndrome, an ultra-rare cancer of mature T lymphocytes
date_range
Duration: from 12 January 2020 to 30 November 2023
(47 months)
